ThromboGenics Announces Start of Phase II Trial of Microplasmin for the … – PR Newswire (press release)
December 11th, 2009
ThromboGenics Announces Start of Phase II Trial of Microplasmin for the …PR Newswire (press release)… announces today that it has started a Phase II trial of microplasmin for the treatment of exudative (wet) Age-related Macular Degeneration (AMD). …
Original post by macular degeneration – Google News
(click on the author/publication link above to see full post)